|
02 Jan 2023 |
Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products Enabled by Alteogen’s Hybrozyme™ Technology
|
|
28 Dec 2022 |
PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates
|
|
28 Dec 2022 |
PeptiDream Announces New Research and Collaboration Agreement with Lilly for the Discovery of Novel Peptide Drug Conjugates
|
|
24 Dec 2022 |
LegoChem Biosciences and Amgen Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates
|
|
22 Dec 2022 |
Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer
|
|
22 Dec 2022 |
Lilly and ProQR to Expand RNA Editing Collaboration
|
|
20 Dec 2022 |
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
|
|
19 Dec 2022 |
Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
|
|
15 Dec 2022 |
GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets
|
|
15 Dec 2022 |
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
|
|
15 Dec 2022 |
Arthex announces regulatory milestones met in its program to develop ATX-01 in Myotonic Dystrophy Type 1
|
|
15 Dec 2022 |
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease
|
|
12 Dec 2022 |
Amgen Inc to Acquire Horizon Therapeutics plc
|
|
08 Dec 2022 |
Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)
|
|
07 Dec 2022 |
MorphoSys Out Licenses Pre-Clinical Oncology Program
|
|
06 Dec 2022 |
Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy
|
|
06 Dec 2022 |
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
|
|
06 Dec 2022 |
Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease
|
|
06 Dec 2022 |
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
|
|
01 Dec 2022 |
Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
|
|
01 Dec 2022 |
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates
|
|
30 Nov 2022 |
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
|
|
29 Nov 2022 |
Envisagenics Announces Research Collaboration with Bristol Myers Squibb
|
|
29 Nov 2022 |
BigHat Biosciences Announces Research Collaboration with Merck
|
|
29 Nov 2022 |
Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim
|
